Development of Lentiviral and CRISPR/Cas Tools for In Vivo Multimodality Reporter Gene Imaging of Cells
Development of Lentiviral and CRISPR/Cas Tools for In Vivo Multimodality Reporter Gene Imaging of Cells
批准号:
548122-2020
负责人:
Shalaby, NourhanNS
金额:
$1.53万
依托单位国家:
加拿大
项目类别:
Postgraduate Scholarships - Doctoral
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
中文摘要
报告基因,治疗,MRI, PET,造影剂,钆,示踪剂,转移,乳腺癌,干细胞
英文摘要
Reporter gene, Theranostic, MRI, PET, contrast agents, Gadolinium, Tracers, Metastasis, Breast cancer, stem cells
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金